Monoclonal Antibodies: a Stanford Story of Academia-Industry Collaboration
Since the 1970s, Ron Levy has been exploring ways to harness the body's immune system to fight cancer. In 1976, he found that it was possible to make monoclonal antibodies that could specifically recognize cancer cells inside the body.